-

Flatiron Health Appoints Nina Chavez, Former COO at New Mexico Cancer Center, as Senior Advisor

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced that Nina Chavez, formerly chief operating officer at New Mexico Oncology Hematology Consultants (NMOHC) at the New Mexico Cancer Center (NMCC), has joined Flatiron as a senior advisor. In this role, Nina will serve as a subject matter expert in value-based care and clinical practice transformation. She will be responsible for creating and implementing solutions to help practices succeed in the dynamic oncology marketplace.

Prior to joining Flatiron, Nina provided leadership and change management to NMCC to promote quality, innovation and clinical excellence. Reporting to the CEO, she helped shape the practice’s strategic direction, to build a top-performing team of 150+ staff and 22+ physicians and APPs. With her team, Nina participated in the expansion of NMCC’s capabilities beyond medical and radiation oncology, creating a multispecialty center offering rheumatology, primary care, palliative care, clinical research and internal medicine to help attract the right patient and payer mix.

“As the complexity of our community oncology landscape, competitive dynamics, and regulatory environment intensifies, it is increasingly important that Flatiron supports practices to drive financial and operational success beyond our core technology and service offerings,” said Carolyn Starrett, SVP of Provider Solutions. “Nina will offer Flatiron’s practices support in the community oncology space by leveraging her 16 years of experience in achieving cancer center business operational excellence.”

Nina participated in the leadership of the effort to transform NMCC into a level III oncology medical home with the National Committee for Quality Assurance, triggering participation in the Oncology Care Model with CMS and increasing Medicare reimbursement in quality adjustments and performance-based payments. She is considered a leading expert in USP800 and dispensing clinic operations, speaking at several national conferences over the years.

Nina previously served on the boards of the Association of Community Cancer Centers, and the Coalition of Hematology and Oncology Practices. Additionally, she is a fellow with the American College of Medical Practice Executives.

“After years of partnership and collaboration, I am excited to be joining Flatiron Health, a company that is dedicated to supporting community oncology,” said Nina Chavez. “I am looking forward to the opportunities that lay ahead to support practice leadership in their efforts to navigate community oncology in the ever-changing healthcare environment.”

For more information about Flatiron’s leading technology platform in community oncology, click here.

About Flatiron Health

Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. Our platform enables cancer researchers and care providers to learn from the experience of every patient. Currently, Flatiron partners with over 280 community cancer practices, seven major academic research centers and over 15 of the top therapeutic oncology companies. For more information, please visit www.flatiron.com or follow us @FlatironHealth.

Contacts

Jenny Edelston
press@flatiron.com

Flatiron Health

Details
Headquarters: New York, NY
CEO: Nathan Hubbard
Employees: 2,500
Organization: PRI

Release Versions

Contacts

Jenny Edelston
press@flatiron.com

More News From Flatiron Health

Flatiron Health Brings 25+ Research Acceptances and Next-Generation Capabilities to ASCO 2026

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Clinical Oncology (ASCO) Annual Meeting happening from May 29 - June 2, 2026, in Chicago, Illinois. Flatiron's high-quality real-world data and innovative research capabilities are featured across 25+ research acceptances, including 14 Flatiron-authored poster presentations and online publications. Flatiron’s presence at ASCO 2026 closely follows the launch of Flatiron Telescope, a multi-agent ada...

New Research Confirms Data Quality as the Defining Priority Across the Real-World Evidence Landscape

NEW YORK--(BUSINESS WIRE)--As oncology grows more complex and the pace of innovation accelerates, life sciences organizations are placing a premium on high-quality, complete, and scalable real-world data. New insights from two independent surveys confirm that data quality and cohort scale are now prerequisites for confident decision-making and insight generation, especially as the industry evolves from retrospective analysis to predictive and AI-driven applications. A survey conducted by Deloit...

Flatiron Health Launches Flatiron Telescope, a New AI Platform Delivering Oncology Insights in Minutes

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the launch of Flatiron Telescope, a next-generation AI-powered platform designed to help life sciences teams and researchers find the right patients faster, assess study feasibility in real time, and generate oncology insights on demand. Built on Flatiron’s industry-leading real-world data and powered by its multi-agent adaptive analytics engine, Flatiron Telescope enables teams across clinical development, RWE, and commercial functions...
Back to Newsroom